We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Iconic Labs Plc | LSE:ICON | London | Ordinary Share | GB00BRBJ3P08 | ORD GBP0.0001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 5.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Health & Allied Services,nec | 0 | 4.77M | 0.5697 | 0.09 | 418.58k |
TIDMICON
RNS Number : 1165F
Iconic Labs PLC
05 March 2020
5 March 2020
Iconic Labs Plc ("Iconic Labs" or the "Company")
Suspension of shares
Iconic Labs Plc (LSE:ICON) (the "Company"), a multi-divisional new media and technology business, has requested the suspension of the listing of the Company's ordinary shares of GBP0.00001 each ("Ordinary Shares") from the standard segment of the Main Market of the London Stock Exchange and it has been suspended from 07:30am today.
This suspension has been requested because it has come to the attention of the Company that in respect of a number of Ordinary Shares issued and allotted by the Company during 2019, not all Form 1 submissions had been submitted, as was required and which relate in part to the securities referred to in the prospectus published by the Company on 22 February 2019 and for which the time period to make such submissions has now expired. The Company intends to address this issue through the approval and publication of a new prospectus and subsequent submission of all required Form 1 submissions.
The Company is in the process of finalising the new prospectus and intends to publish this new prospectus as soon as final approval is granted by the Financial Conduct Authority. Following approval and publication of the new prospectus, the Form 1 submissions will be made as soon as is possible thereafter.
The Company hopes to be able to publish the new prospectus within two weeks, but will update the market as to progress.
**ENDS**
For further information, please visit the Company's website www.iconiclabs.co.uk or contact:
Damon Heath Shard Capital Partners Tel: +44 (0) 20 7186 9950 LLP
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
SUSDELBBBXLXBBZ
(END) Dow Jones Newswires
March 05, 2020 02:35 ET (07:35 GMT)
1 Year Iconic Labs Chart |
1 Month Iconic Labs Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions